文献

J-GLOBAL ID：201702267935520857   整理番号：17A1688560

上皮増殖因子受容体(EGFR)T790M陽性非小細胞肺癌へのオシメルチニブに誘発された間質性肺疾患

Interstitial Lung Disease Induced by Osimertinib for Epidermal Growth Factor Receptor (EGFR) T790M-positive Non-small Cell Lung Cancer

著者 (14件)： Matsumoto Yoshiya (Department of Respiratory Medicine, Graduate School of Medicine, Osaka City University, Japan) ,  Kawaguchi Tomoya (Department of Respiratory Medicine, Graduate School of Medicine, Osaka City University, Japan) ,  Kawaguchi Tomoya (Department of Clinical Oncology, Graduate School of Medicine, Osaka City University, Japan) ,  Yamamoto Norio (Department of Respiratory Medicine, Graduate School of Medicine, Osaka City University, Japan) ,  Sawa Kenji (Department of Respiratory Medicine, Graduate School of Medicine, Osaka City University, Japan) ,  Yoshimoto Naoki (Department of Clinical Oncology, Graduate School of Medicine, Osaka City University, Japan) ,  Suzumura Tomohiro (Department of Clinical Oncology, Graduate School of Medicine, Osaka City University, Japan) ,  Watanabe Tetsuya (Department of Respiratory Medicine, Graduate School of Medicine, Osaka City University, Japan) ,  Mitsuoka Shigeki (Department of Clinical Oncology, Graduate School of Medicine, Osaka City University, Japan) ,  Asai Kazuhisa (Department of Respiratory Medicine, Graduate School of Medicine, Osaka City University, Japan) ,  Kimura Tatsuo (Department of Premier Preventive Medicine, Graduate School of Medicine, Osaka City University, Japan) ,  Yoshimura Naruo (Department of Clinical Oncology, Graduate School of Medicine, Osaka City University, Japan) ,  Kuwae Yuko (Department of Pathology, Graduate School of Medicine, Osaka City University, Japan) ,  Hirata Kazuto (Department of Respiratory Medicine, Graduate School of Medicine, Osaka City University, Japan)
資料名： Internal Medicine (Web)  (Internal Medicine (Web))
巻： 56  号： 17  ページ： 2325-2328(J-STAGE)  発行年： 2017年 
JST資料番号： U0033A  ISSN： 1349-7235  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： ステージIVの肺腺癌の75歳男性が,エルロチニブが投与されて...

シソーラス用語： ヒト ,...
準シソーラス用語： *間質性肺疾患 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1688560&from=J-GLOBAL&jstjournalNo=U0033A") }}

著者キーワード (6件)： epidermal growth factor receptor ,  T790M resistance mutation ,  osimertinib ,  non-small cell lung cancer ,  interstitial lung disease ,  transbronchial lung biopsy

分類 (1件)： 呼吸器の疾患  (GI03000Z)

物質索引 (1件)： オシメルチニブ

引用文献 (16件)：

• 1. Mok TS, Wu YL, Thongprasert S, et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 361: 947-957, 2009.
• 2. Maemondo M, Inoue A, Kobayashi K, et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med 362: 2380-2388, 2010.
• 3. Rosell R, Carcereny E, Gervais R, et al. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol 13: 239-246, 2012.
• 4. Sequist LV, Yang JC, Yamamoto N, et al. Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations. J Clin Oncol 31: 3327-3334, 2013.
• 5. Yu HA, Arcila ME, Rekhtman N, et al. Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers. Clin Cancer Res 19: 2240-2247, 2013.

タイトルに関連する用語 (6件)： 上皮増殖因子受容体 ,  EGFR ,  非小細胞肺癌 ,  オシメルチニブ ,  誘発 ,  間質性肺疾患